About FYI Diabetes
Working toward a functional cure — and what it could mean for the people who live with diabetes.
We are a group of people — families, scientists, and builders — who believe diabetes is a problem worth solving, not only a condition worth managing. We raise the money that funds promising research, and we help people understand the science that could change what living with this disease means.
A small organization with a single, stubborn goal.
FYI Diabetes funds scientific research aimed at restoring the body’s own ability to manage blood sugar, and we raise awareness so that families facing a diagnosis know what the science is actually working toward. Our focus is twofold: fund the research that takes the hardest questions seriously, and make sure the people who live with diabetes — many of them diagnosed as children — aren’t left out of the conversation about their own future.
Every project we back is chosen because it targets the disease itself, not just the daily work of managing it.
The people behind the mission.
- Co-authored a peer-reviewed clinical study on NeuropAWAY®, published in the PubMed-indexed Journal of Pain Research — wrote the protocol, raised the funding, and published the results
- Holds 8 proprietary patents for nutraceutical and pharmaceutical formulations
- Founder of VasoCorp, scaled nationwide through major retail partners
- Sponsors “Second Saturday” health screenings at H-E-B stores across Texas
- Founder of Atlanta’s Law Firm, LLC, a leading Atlanta criminal-defense practice
- Pitched alongside William in national business-plan competitions to raise awareness of his patented formulations
- Leads FYI Diabetes’ fundraising efforts and remains the nonprofit’s most steadfast champion — a lawyer by training, a sister by calling
- CEO of SFC Fluidics, leading the development and commercialization of an advanced insulin pump
- 20+ year MedTech executive — former leadership at US Surgical (Covidien), BD, and Facet Technologies, LLC
- Proven record: guided 2 major biotech companies to successful exits ($12B+ collectively)
- Driving capital raise for upcoming porcine and human trials via established relationships
The science only moves as fast as the people willing to fund it.
If you believe diabetes is worth solving, the most direct thing you can do is help fund the next step.
See the Research & Give